Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized dexmedetomidine-lidocaine for awake endotracheal intubation in adults
ChiCTR2100052469Phase 4Recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and lidocaine in difficult airway and obstructive sleep apnea hypopnea syndrome (OSAHS) (3 arms), sponsored by Xuzhou Central Hospital. Primary endpoints: Observer's Assessment of Alertness/Sedation (OAA/S), Heart rate and 3 more. Started Nov 2021; status: recruiting.
02
Drugs
dexmedetomidinelidocaine
03
Conditions
difficult airwayobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2100052469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052469.